-
Small cell lung carcinoma
- Effects: cushing's syndrome, SIADH, Lambert-Eaton Syndrome (muscle weakness)
- Hormone/agent secreted: ACTH or like peptide, ADH, Antibodies against presynaptic Ca2+ channels at neuromuscular junction
-
Intracranial neoplasms
- Effect: SIADH
- Hormone: ADH
-
Squamous cell lung carcinoma
- Effect: hypercalcemia
- Hormone/agent: PTH-related pepetide, TGF-b, TNF, IL-1
-
Breast carcinoma
- Effect: hypercalcemia
- Hormone/agent: PTH-related pepetide, TGF-b, TNF, IL-1
-
Renal cell carcinoma
- Effect: hypercalcemia, polycythemia
- Hormone/agent: PTH-related pepetide, TGF-b, TNF, IL-1, erythropoietin
-
Hemangioblastoma, hepatocellular carcinoma, pheochromocytoma
- Effect: polycythemia
- hormone/agent: erythropoietin
-
Thymomoa
- Effect: Lambert-Eaton syndrome (muscle weakness)
- Hormone/agent: Antibodies against presynaptic Ca2+ channels at neuromuscular junction
-
Leukemias and lymphomas
- Effect: gout, urate nephropathy
- Hormone/agent: hyperuricemia due to excess nucleic acid turnover
|
|